Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer

ADT and acute kidney injury—causal or casual relationship?

Nature Reviews Endocrinology volume 9, pages 568–570 (2013)Cite this article

Subjects

A recent observational study has reported that androgen deprivation therapy for prostate cancer is associated with an increased risk of acute kidney injury. As a result of limited biological plausibility and critical measured and unmeasured confounders, the reported link is more likely to be casual than causal.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Sharifi, N., Gulley, J. L. & Dahut, W. L. An update on androgen deprivation therapy for prostate cancer. Endocr. Relat. Cancer 17, R305–R315 (2010).

    Article  CAS  Google Scholar 

  2. Lapi, F. et al. Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer. JAMA 310, 289–296 (2013).

    Article  CAS  Google Scholar 

  3. Saylor, P. J. & Smith, M. R. Metabolic complications of androgen deprivation therapy for prostate cancer. J. Urol. 181, 1998–2006 (2009).

    Article  CAS  Google Scholar 

  4. Keating, N. L., O'Malley, A. J. & Smith, M. R. Diabetes and cardiovascular disease during androgen deprivation for prostate cancer. J. Clin. Oncol. 24, 4448–4456 (2006).

    Article  CAS  Google Scholar 

  5. Alibhai, S. M. et al. Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. J. Clin. Oncol. 28, 5038–5045 (2010).

    Article  CAS  Google Scholar 

  6. Smith, M. R. et al. Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition. J. Clin. Oncol. 22, 2546–2553 (2004).

    Article  CAS  Google Scholar 

  7. Shahinian, V. B., Kuo, Y.-F., Freeman, J. L. & Goodwin, J. S. Risk of fracture after androgen deprivation for prostate cancer. N. Engl. J. Med. 352, 154–164 (2005).

    Article  CAS  Google Scholar 

  8. Smith, M. R. et al. Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer. J. Urol. 175, 136–139 (2006).

    Article  CAS  Google Scholar 

  9. National Institute for Health and Care Excellence. NICE Clinical guideline 58: Prostate cancer: diagnosis and treatment [online], (2008).

  10. Perazella, M. A. & Markowitz, G. S. Bisphosphonate nephrotoxicity. Kidney Int. 74, 1385–1393 (2008).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Massachusetts General Hospital Cancer Center, Yawkey 7030, 55 Fruit Street, Boston, 02114, MA, USA

    Matthew R. Smith

Authors
  1. Matthew R. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, M. ADT and acute kidney injury—causal or casual relationship?. Nat Rev Endocrinol 9, 568–570 (2013). https://doi.org/10.1038/nrendo.2013.167

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2013.167

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing